ArticleStem cell research & therapy2020

The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice.

Yexing Xian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.